Aditi Panandikar, managing director of Indoco Remedies, said the certification reflects the company's commitment to supplying high-quality products to patients across the globe.
Meanwhile, ICICI Prudential Mutual Fund acquired 13,58,002 shares, or a 1.47% stake, in Indoco Remedies through bulk deals on 27 May 2026. Exchange data showed that the fund bought 6,83,544 shares on the NSE and 6,74,458 shares on the BSE at Rs 198 per share. The total deal value stood at around Rs 26.88 crore.
Indoco Remedies is a fully integrated pharmaceutical company with 10 manufacturing facilities, including six formulations plants and four API units. The company caters to domestic and international markets across multiple therapeutic segments and maintains partnerships with generic drug companies worldwide.
On a consolidated basis, Indoco Remedies reported net loss of Rs 21.64 crore in Q4 March 2026 as against net loss of Rs 40.39 crore in Q4 March 2025. Net sales rose 18.76% YoY to Rs 455.90 crore in Q4 March 2026.
"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."